AstraZeneca’s Corona vaccine trial ban on children and teenagers in Britain- The trial of the Oxford-AstraZeneca Covid-19 vaccine on children and adolescents aged 6 to 17 has been stopped. Oxford University itself has given information about this. Actually, some people who have been given the AstraZeneki vaccine have done so after receiving complaints of blood clots. The Wall Street Journal reported this. According to the news, now the trial will be started only after getting more information about the formation of blood clots.
However, an Oxford spokesperson said on Tuesday that the trial has not been stopped due to safety concerns but is awaiting UK drug regulator guidelines on its use. Explain that there are widespread concerns in the UK and Europe about the problems of blood clotting in adults.
AstraZeneca’s Corona vaccine trial ban on children and teenagers in Britain
Earlier, the European Medicines Agency (EMA) said that it was investigating problems faced by patients taking the first dose of AstraZeneca vaccine in European countries.
Several European countries suspended the use of the AstraZeneca vaccine, including Austria, Estonia, Lithuania, Latvia, Luxembourg, Denmark, Bulgaria, Norway, Iceland, Slovenia, Cyprus, Italy, France, Germany, and Spain. The EMA subsequently recommended continuing use of the drug. After which many countries have started vaccination again with this vaccine.
In recent times, the question has been raised whether the use of AstraZeneca’s Covid-19 vaccine is rare among serious but not serious cases of blood clots.
AstraZeneca has banned testing in children in the UK after reports of blood clots forming in the Covid vaccine. Oxford University issued a statement on Tuesday asking to review reports of blood clotting in adults. Has been Until its cause is known, the children will not be given the AstraZeneca Corona vaccine.
The trial was to be held on 300 children
Let me tell you that Britain’s Oxford University started a trial of the coronavirus vaccine on children. During this time, children were being given a dose of the Oxford-AstraZeneca vaccine. The trial was being conducted on 300 children in the age group of six to 17 years, but the news has been stopped after reports of blood clots in vaccine users.
Many countries put a ban on vaccine
In March, governments in several countries, including Italy, banned vaccination with AstraZeneca’s COVID-19 vaccine. After the vaccine was stopped, the European Medicines Agency (EMA) clarified that its benefits outweigh the risks and should continue in use. But it also said that there could be a possibility of a relationship between the vaccine and blood clots, and a revised assessment is expected to be released this week.
